Clinical Trials Browser

Phase 2/3 × OTHER × Atorvastatin × Clear all

NCT05103644 2022-11-02

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Phase 2/3 Unknown

Breast Neoplasms